The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Medication usage change in older people (65+) in England over 20 years: findings from CFAS I and CFAS II
Open accessAbstract
Background: medical practice has changed over the last decades reflecting the ageing population, when multi-morbidity requiring multiple medications is more common. Objective: describe and quantify self-reported medicine use including both prescription and over the counter medicines in two comparable population-based studies of older people (65+) in England and to assess the nature and scale of polypharmacy. Methods: data used were from two separate population-based studies; the Cognitive Function Ageing Study I and II. Descriptive analyses were performed to summarise and quantify general medicine use. Negative binomial regression models were fitted to determine factors associated with the number of medicines used. Results: medication use, including both prescribed medicines and over the counter products has increased dramatically over the last 2 decades. The number of people taking five or more items quadrupled from 12 to 49%, while the proportion of people who did not take any medication has decreased from around 1 in 5 to 1 in 13. Cardiovascular drugs were the most frequently taken medication. Polypharmacy is associated with increases in the number of diagnosed long-term conditions. Conclusions: comparison between CFAS I and II reveals marked increases in medication usage and polypharmacy in the older population. The influence of healthcare organisation, introduction of new guidelines and technology changes leading to diagnosis of earlier, milder chronic diseases and treatment may be contributing to this changing pattern. Further research is needed to develop practical solutions to optimise medication management in older people, reducing the harming associated with medication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Middle aged and older populations are increasingly taking multiple drugs, but the potential adverse events of long term use are not well understood.
“Middle aged and older populations are increasingly taking multiple drugs,6 7 but the potential adverse events of long term use are not well understood.”
From Anticholinergic drugs and risk of dementia: case-control study (2018) · cites this paper as [6]
The supplied Results and Discussion passages concern health conditions and functional deficits among people entering care homes, not medication use. Searches for increasing use of multiple drugs and polypharmacy returned the same unrelated passages, so our copy does not verify the claim attributed to this source. The statement about adverse events follows the citations and is not the part judged here. (LLM, conf=0.76)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polypharmacy Among Adults Aged 65 Years and Older in the United States: 1988–2010
Charlesworth, C. J., Smit, E., Lee, D. S. H., Alramadhan, F., & Odden, M. C. (2015) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glv013 · Cited by 570
Flagged first, then by citations
Research works printed but not linked: 18
- Bunker, 2001, The role of medical care in contributing to health improvements within societies, Int J Epidemiol, 30, 1260, 10.1093/ije/30.6.1260 · DOI
- Francis, 2005, Switching of prescription drugs to over-the-counter status. Is it a good thing for the elderly?, Drugs Aging, 22, 361, 10.2165/00002512-200522050-00001 · DOI
- Matthews, 2013, A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II, Lancet, 6736, 4
- Guthrie, 2015, The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010, BMC Med, 13, 74, 10.1186/s12916-015-0322-7 · DOI
- Franchi, 2014, Changes in drug prescribing to Italian community-dwelling elderly people: the EPIFARM—Elderly Project 2000–2010, Eur J Clin Pharmacol, 70, 437, 10.1007/s00228-013-1621-6 · DOI
- UK D, 2011, Key Statistics on Diabetes
- Moynihan, 2012, Preventing overdiagnosis: how to stop harming the healthy, Br Med J, 344, e3502, 10.1136/bmj.e3502 · DOI · Paper page
- Nichols, 2013, Cardiovascular disease in Europe: epidemiological update, Eur Heart J, 34, 3028, 10.1093/eurheartj/eht356 · DOI
- Hajjar, 2007, Polypharmacy in elderly patients, Am J Geriatr Pharmacother, 5, 345, 10.1016/j.amjopharm.2007.12.002 · DOI
- Cahir, 2010, Potentially inappropriate prescribing and cost outcomes for older people: a national population study, Br J Clin Pharmacol, 69, 543, 10.1111/j.1365-2125.2010.03628.x · DOI
- Barry, 2016, Potentially inappropriate prescribing among people with dementia in primary care: a retrospective cross-sectional study using the enhanced prescribing database, J Alzheimers Dis, 52, 1503, 10.3233/JAD-151177 · DOI
- Parsons, 2010, Withholding, discontinuing, and withdrawing medications in dementia patients at the end of life: a neglected problem in the disadvantaged dying?, Drugs Aging, 27, 435, 10.2165/11536760-000000000-00000 · DOI
- Spinewine, 2007, Appropriate prescribing in elderly people: how well can it be measured and optimised?, Lancet, 370, 173, 10.1016/S0140-6736(07)61091-5 · DOI
- Fox, 2011, Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study, J Am Geriatr Soc, 59, 1477, 10.1111/j.1532-5415.2011.03491.x · DOI · Paper page
- Elwyn, 2016, Clinical encounters in the post-guidelines era, Br Med J, 353, i3200, 10.1136/bmj.i3200 · DOI
- Scott, 2015, Reducing inappropriate polypharmacy: the process of deprescribing, JAMA Intern Med, 175, 827, 10.1001/jamainternmed.2015.0324 · DOI
- Howland, 2009, Medication Holidays, J Psychosoc Nurs Ment Health Serv, 47, 15
- Beers, 1997, Explicit criteria for determining potentially inappropriate medication use by the elderly: an update, Arch Intern Med, 10.1001/archinte.1997.00440350031003 · DOI
Cited by
Sorted by citations
Anticholinergic drugs and risk of dementia: case-control study
Richardson, K., Fox, C., Maidment, I., Steel, N., Loke, Y. K., Arthur, A., Myint, P. K., Grossi, C. M., Mattishent, K., Bennett, K., et al. (2018) · BMJ · doi:10.1136/bmj.k1315 · Cited by 520
Self-citationBiobank, O. B. O. D. P. U. A. U., Wilkinson, T., Schnier, C., Bush, K., Rannikmäe, K., Henshall, D. E., Lerpiniere, C., Allen, N. E., Flaig, R., Russ, T. C., et al. (2019) · European Journal of Epidemiology · doi:10.1007/s10654-019-00499-1 · Cited by 452
How to manage comorbidities in people with dementia: A scoping review
Ma, D., Wang, Y., Zhao, Y., Meng, X., Su, J., Zhi, S., Song, D., Gao, S., Sun, J., & Sun, J. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101937 · Cited by 25
Metadata
- Authors
- Gao, L., Maidment, I., Matthews, F. E., Robinson, L., Brayne, C., & on behalf of the Medical Research Council Cognitive Function and Ageing Study
- Affiliations
- MRC Biostatistics Unit (GB)
- Aston University (GB)
- Newcastle University (GB)
- University of Cambridge (GB)
- Corresponding author
- Brayne, Carol
- Venue
- Age and Ageing
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-09-26
- Volume
- 47
- Issue
- 2
- Pages
- 220-225
- ISSN
- 0002-0729 (ISSN-L)
- 1468-2834
- PMC
- PMC6037294
- OpenAlex
- W2763066659
- Cited by
- 123
- References
- 2
- Citations by year
- 2026: 12 · 2025: 11 · 2024: 14 · 2023: 18 · 2022: 16 · 2021: 17 · 2020: 18 · 2019: 9 · 2018: 6 · 2017: 2
- FWCI
- 8.01
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- cc-by
- Locations
- Age and Ageing (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion, cc-by)
- PubMed Central (acceptedVersion, cc-by)
- Aston Publications Explorer (Aston University) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Repository@Hull (Worktribe) (University of Hull) (submittedVersion, cc-by)
- Repository@Hull (Worktribe) (University of Hull) (submittedVersion)
- Apollo
- Funders
- Department of Health
- Medical Research Council
- The National Institute of Health Research (G9901400, G0601022)
- MRC (U105292687)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
- Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
- Keywords
- medication use, polypharmacy, older adults, over-the-counter drugs, prescription drugs, chronic disease, cardiovascular drugs, temporal trends, medication management
- MeSH terms
- Age Factors, Aged, Drug Therapy, Nonprescription Drugs, England, Geriatrics, Health Status, Humans, Longitudinal Studies, Practice Patterns, Physicians', Drug Prescriptions, State Medicine, Time Factors, Polypharmacy, Prescription Drugs, Self Report
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review